Stereotaxis Inc Asset Resilience Ratio
Stereotaxis Inc asset resilience ratio. Stereotaxis Inc (STXS) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See STXS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Stereotaxis Inc (2003–2023)
Asset resilience ratio of Stereotaxis Inc from 2003 to 2023. This chart shows how Stereotaxis Inc's Asset Resilience Ratio has changed over time. Read STXS liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Stereotaxis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see STXS total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Stereotaxis Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Stereotaxis Inc Industry Peers by Asset Resilience Ratio
Compare Stereotaxis Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0 |
Medical Instruments & Supplies | 0.37% |
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101 |
Medical Instruments & Supplies | 47.21% |
|
Medeon Biodesign
TWO:6499 |
Medical Instruments & Supplies | 32.68% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Nextgen
TA:NXGN |
Medical Instruments & Supplies | 3.13% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Stereotaxis Inc Asset Resilience Ratio by Year (2003–2023)
Stereotaxis Inc asset resilience ratio by year from 2003 to 2023. The table below shows the annual Asset Resilience Ratio data for Stereotaxis Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $41.91 Million | -- |
| 2022-12-31 | 37.15% | $19.84 Million | $53.41 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $60.98 Million | -- |
| 2012-12-31 | 3.24% | $1.04 Million | $32.17 Million | -7.73pp |
| 2007-12-31 | 10.97% | $6.63 Million | $60.48 Million | -20.45pp |
| 2006-12-31 | 31.42% | $21.77 Million | $69.29 Million | +16.35pp |
| 2005-12-31 | 15.07% | $5.52 Million | $36.66 Million | -25.30pp |
| 2004-12-31 | 40.37% | $28.74 Million | $71.19 Million | +26.64pp |
| 2003-12-31 | 13.73% | $5.12 Million | $37.32 Million | -- |
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more